Probiotics for Autism
((PROBI-O-TISM) Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a daily Bio-K+ probiotic supplement can reduce the severity of behaviors and related issues in children with autism spectrum disorder (ASD). The study assesses the effects of probiotics on behaviors, gut health, and sleep quality using a controlled method. Some children receive the probiotic, while others receive a look-alike drink without active ingredients. This simple and promising approach may improve the lives of children with ASD and their families. Suitable candidates for this trial have an autism diagnosis, normal intelligence, and can consume the probiotic drink. As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research that could enhance the quality of life for children with ASD.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have taken antibiotics or probiotics in the last 3 months.
What prior data suggests that Bio-K+ probiotics are safe for children with autism?
In a previous study, researchers found that the Bio-K+ probiotic drink is safe and suitable for autistic children aged 4 to 11. The study showed that children tolerated the probiotics well, with no serious side effects. This finding suggests that adding Bio-K+ probiotics to the daily routine of children with autism might be a low-risk option to consider.12345
Why are researchers excited about this trial?
Unlike the standard treatments for autism, which often include behavioral therapies and medications targeting symptoms like irritability, Bio-K+ Probiotics introduces a novel approach by using live bacteria to potentially influence gut health and, in turn, impact behavior. Researchers are excited about this treatment because it leverages the gut-brain axis, a pathway that is gaining attention for its role in neurological conditions. This probiotic beverage contains three specific lactobacilli, which are believed to promote a healthier gut microbiome. By focusing on the gut's influence on the brain, this treatment could offer a more natural and holistic option for managing autism symptoms.
What evidence suggests that Bio-K+ probiotics might be an effective treatment for autism?
Research has shown that Bio-K+ probiotics, which participants in this trial may receive, might help with behaviors and symptoms related to autism spectrum disorder (ASD). Early results from a small study found that these probiotics improved behavior, digestive issues, and sleep in children with autism. The study also confirmed that the Bio-K+ probiotic drink is safe and easy for children with ASD to take. While more research is needed, these early findings suggest that Bio-K+ probiotics could be a helpful option for managing some autism symptoms.12346
Who Is on the Research Team?
Valérie Marcil, Professor
Principal Investigator
St. Justine's Hospital
Are You a Good Fit for This Trial?
This trial is for children aged 4 to 11 with Autism Spectrum Disorder (ASD). They should have stereotyped behaviors and may also experience gastrointestinal issues or sleep disturbances. Children who've previously tolerated the Bio-K+ probiotic beverage are eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a daily Bio-K+ probiotic supplement for 14 weeks
Follow-up
Participants are monitored for persistence of treatment effects after wash-out
What Are the Treatments Tested in This Trial?
Interventions
- Bio-K+ Probiotics
Find a Clinic Near You
Who Is Running the Clinical Trial?
Valérie Marcil
Lead Sponsor
Hôpital du Sacré-Coeur de Montréal (CIUSSS - NIM)
Collaborator
University of Ottawa
Collaborator
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborator
Institut National de la Recherche Scientifique - Centre Armand Frappier Santé Biotechnologie
Collaborator